High-dose chemotherapy followed by reinfusion of selected CD34+ peripheral blood cells in patients with poor-prognosis breast cancer: a randomized multicentre study.
Chabannon C, Cornetta K, Lotz JP, Rosenfeld C, Shlomchik M, Yanovitch S, Marolleau JP, Sledge G, Novakovitch G, Srour EF, Burtness B, Camerlo J, Gravis G, Lee-Fischer J, Faucher C, Chabbert I, Krause D, Maraninchi D, Mills B, Kunkel L, Oldham F, Blaise D, Viens P.
Chabannon C, et al. Among authors: shlomchik m.
Br J Cancer. 1998 Oct;78(7):913-21. doi: 10.1038/bjc.1998.601.
Br J Cancer. 1998.
PMID: 9764583
Free PMC article.
Clinical Trial.